Instrumento Inactivo

Otros idiomas Cronos Group Inc Toronto S.E.

Acciones

Cronos Shares Jump as Q1 Loss Narrows, Revenue Rises	09/05
Cronos Group Up 3.9% in U.S. Premarket Trade as Q1 Loss Narrows on Higher Sales	09/05
Cronos: Q1 Earnings Snapshot	09/05
Cronos Group Brief: Q1 Net Loss $2.484 Million	09/05
Cronos Group Brief: Citing Balance Sheet with US$855 Million in Cash and Cash Equivalents	09/05
Cronos Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Cronos Group Brief: Q1 Consolidated net revenue US$25.288 Million	09/05
Cronos Group Reports 2024 First Quarter Results	09/05
Cronos Group Enters U.K. Cannabis Market	07/05
Cronos Group Brief: Entering United Kingdom Cannabis Market	07/05
Cronos Enters United Kingdom Cannabis Market	07/05
Cronos Enters United Kingdom Cannabis Market	07/05
Sector Update: Consumer Stocks Slipping in Late Afternoon Trading	30/04
Cannabis Stocks Jump on Report DEA to Reclassify Marijuana as Less Dangerous Drug	30/04
Cannabis Stocks Rise on Media Report of DEA Reclassifying Marijuana as Less Dangerous Drug	30/04
DEA to Move to Reclassify Marijuana, Associated Press Reports	30/04
Cronos Group Inc. to Hold Virtual 2024 Annual Meeting of Shareholders	29/04
Cronos Group Inc. to Hold Virtual 2024 Annual Meeting of Shareholders	26/04
Cronos Group Inc. to Hold 2024 First Quarter Earnings Conference Call on May 9, 2024	25/04
Cronos : Change in Certifying Accountants - Form 8-K	17/04

No hay resultados para esta búsqueda